996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

Basic Info

  • Grade: Injection Grade

    Factory Location: No. 369, South Yuzhou Rd. Lianyungang, Jiangsu, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/L

    Fulvestrant injection, an injection for intramuscular administration,
    is supplied as 250 mg/5 mL fulvestrant.
    It is an an estrogen receptor antagonist indicated
    for the treatment of:
    · Hormone receptor (HR)-positive advanced breast cancer in
    postmenopausal women with disease progression following
    endocrine therapy. (1)
    · HR-positive, HER2-negative advanced or metastatic breast
    cancer in postmenopausal women in combination with
    ribociclib, as initial endocrine based therapy or following
    disease progression on endocrine therapy. (1)
    · HR-positive, HER2-negative advanced or metastatic breast
    cancer in combination with palbociclib or abemaciclib in
    women with disease progression after endocrine therapy

Send your message to this supplier
  • From:
  • To:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service